Alpha-Synuclein Aggregation Induced by Brief Ischemia Negatively Impacts Neuronal Survival in vivo: A Study in [A30P]alpha-Synuclein Transgenic Mouse
Open Access
- 29 September 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 31 (3) , 913-923
Abstract
Alpha-synuclein oligomerization and aggregation are considered to have a role in the pathogenesis of neurodegenerative diseases. However, despite numerous in vitro studies, the impact of aggregates in the intact brain is unclear. In vitro, oxidative/nitrative stress and acidity induce α-synuclein oligomerization. These conditions favoring α-synuclein fibrillization are present in the ischemic brain, which may serve as an in vivo model to study α-synuclein aggregation. In this study, we show that 30-minute proximal middle cerebral artery (MCA) occlusion and 72 hours reperfusion induce oligomerization of wild-type α-synuclein in the ischemic mouse brain. The nonamyloidogenic isoform β-synuclein did not form oligomers. Alpha-synuclein aggregates were confined to neurons and colocalized with ubiquitin immunoreactivity. We also found that 30 minutes proximal MCA occlusion and 24 hours reperfusion induced larger infarcts in C57BL/6(Thy1)-h[A30P]alphaSYN transgenic mice, which have an increased tendency to form synuclein fibrils. Trangenics also developed more selective neuronal necrosis when subjected to 20 minutes distal MCA occlusion and 72 hours reperfusion. Enhanced 3-nitrotyrosine immunoreactivity in transgenic mice suggests that oxidative/nitrative stress may be one of the mechanisms mediating aggregate toxicity. Thus, the increased vulnerability of transgenic mice to ischemia suggests that α-synuclein aggregates not only form during ischemia but also negatively impact neuronal survival, supporting the idea that α-synuclein misfolding may be neurotoxic.Keywords
This publication has 51 references indexed in Scilit:
- Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humansExperimental Neurology, 2007
- Mechanisms of Parkinson's Disease Linked to Pathological α-Synuclein: New Targets for Drug DiscoveryNeuron, 2006
- VEGF Protects Brain against Focal Ischemia without Increasing Blood–Brain Permeability When Administered IntracerebroventricularlyJournal of Cerebral Blood Flow & Metabolism, 2005
- α‐Synuclein pathology does not predict extrapyramidal symptoms or dementiaAnnals of Neurology, 2004
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insultJournal of Neurochemistry, 2001
- Role of Endothelial Nitric Oxide Generation and Peroxynitrite Formation in Reperfusion Injury After Focal Cerebral IschemiaStroke, 2000
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's diseaseNature Genetics, 1998
- Identification of two distinct synucleins from human brainFEBS Letters, 1994